Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long-chain fatty acids are a class of fatty acids with hydrocarbon chains containing 13–21 carbon atoms and a terminal carboxyl group. They comprise both saturated and unsaturated species, are critical constituents of all cells as membrane lipid components, and serve as the body's principal energy stores in adipose tissue. They also give rise to bioactive lipid mediators (e.g., prostaglandins) that participate in inflammation, platelet aggregation, blood pressure regulation, and immune function. Some, such as linoleic acid and alpha-linolenic acid, are essential and must be acquired from the diet. Others, like palmitic acid and stearic acid, are synthesized endogenously. The balance and specific composition of LCFAs in the body strongly influence cardiovascular, metabolic, and inflammatory disease risk.
Not applicable as a drug target. For associated enzymes (e.g., fatty acid synthase, elongases): enzyme inhibition or activation. Omega-3 fatty acids: anti-inflammatory effects, modulation of gene expression (PPAR activation), competition with arachidonic acid for eicosanoid synthesis.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long-chain fatty acid (LCFA).